Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Perspective
  • Published:

Engineering GPCR signaling pathways with RASSLs

Nature Methods volume 5, pages 673–678 (2008)Cite this article

Abstract

We are creating families of designer G protein–coupled receptors (GPCRs) to allow for precise spatiotemporal control of GPCR signaling in vivo. These engineered GPCRs, called receptors activated solely by synthetic ligands (RASSLs), are unresponsive to endogenous ligands but can be activated by nanomolar concentrations of pharmacologically inert, drug-like small molecules. Currently, RASSLs exist for the three major GPCR signaling pathways (Gs, Gi and Gq). We review these advances here to facilitate the use of these powerful and diverse tools.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Creating RASSLs by targeted mutagenesis.
Figure 2: Ligand-dependent and -independent phenotypes are induced by tissue-specific expression of a hRO-i, a Gi RASSL.
Figure 3: Directed molecular evolution to create new RASSLs.

Similar content being viewed by others

References

  1. Armbruster, B.N. & Roth, B.L. Mining the receptorome. J. Biol. Chem. 280, 5129–5132 (2005).

    Article  CAS  Google Scholar 

  2. Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159–1204 (2005).

    Article  CAS  Google Scholar 

  3. Spiegel, A.M. & Weinstein, L.S. Inherited diseases involving G proteins and G protein-coupled receptors. Annu. Rev. Med. 55, 27–39 (2004).

    Article  CAS  Google Scholar 

  4. Hopkins, A.L. & Groom, C.R. The druggable genome. Nat. Rev. Drug Discov. 1, 727–730 (2002).

    Article  CAS  Google Scholar 

  5. Coward, P. et al. Controlling signaling with a specifically designed Gi-coupled receptor. Proc. Natl. Acad. Sci. USA 95, 352–357 (1998).

    Article  CAS  Google Scholar 

  6. Small, K.M., Brown, K.M., Forbes, S.L. & Liggett, S.B. Modification of the beta 2-adrenergic receptor to engineer a receptor-effector complex for gene therapy. J. Biol. Chem. 276, 31596–31601 (2001).

    Article  CAS  Google Scholar 

  7. Jacobson, K.A., Gao, Z.G. & Liang, B.T. Neoceptors: reengineering GPCRs to recognize tailored ligands. Trends Pharmacol. Sci. 28, 111–116 (2007).

    Article  CAS  Google Scholar 

  8. Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S. & Roth, B.L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163–5168 (2007).

    Article  Google Scholar 

  9. Strader, C.D. et al. Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 266, 5–8 (1991).

    CAS  PubMed  Google Scholar 

  10. Ballesteros, J.A. & Weinstein, H. Integrated methods for modeling G-protein coupled receptors. Meth. Neurosci. 25, 366–428 (1995).

    Article  CAS  Google Scholar 

  11. Redfern, C.H. et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat. Biotechnol. 17, 165–169 (1999).

    Article  CAS  Google Scholar 

  12. Mueller, K.L. et al. The receptors and coding logic for bitter taste. Nature 434, 225–229 (2005).

    Article  CAS  Google Scholar 

  13. Zhao, G.Q. et al. The receptors for mammalian sweet and umami taste. Cell 115, 255–266 (2003).

    Article  CAS  Google Scholar 

  14. Redfern, C.H. et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc. Natl. Acad. Sci. USA 97, 4826–4831 (2000).

    Article  CAS  Google Scholar 

  15. Sweger, E.J., Casper, K.B., Scearce-Levie, K., Conklin, B.R. & McCarthy, K.D. Development of hydrocephalus in mice expressing the G(i)-coupled GPCR Ro1 RASSL receptor in astrocytes. J. Neurosci. 27, 2309–2317 (2007).

    Article  CAS  Google Scholar 

  16. Peng, J. et al. Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinol. 149, 1329–1337 (2007).

    Article  Google Scholar 

  17. Claeysen, S., Joubert, L., Sebben, M., Bockaert, J. & Dumuis, A. A single mutation in the 5–HT4 receptor (5–HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL). J. Biol. Chem. 278, 699–702 (2003).

    Article  CAS  Google Scholar 

  18. Bruysters, M., Jongejan, A., Akdemir, A., Bakker, R.A. & Leurs, R.A.G. (q/11)-coupled mutant histamine H(1) receptor F435A activated solely by synthetic ligands (RASSL). J. Biol. Chem. 280, 34741–34746 (2005).

    Article  CAS  Google Scholar 

  19. Kristiansen, K. et al. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a “salt-bridge disruption” mechanism. J. Pharmacol. Exp. Ther. 293, 735–746 (2000).

    CAS  PubMed  Google Scholar 

  20. Srinivasan, S., Santiago, P., Lubrano, C., Vaisse, C. & Conklin, B.R. Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS ONE 2, e668 (2007).

    Article  Google Scholar 

  21. Chang, W.C. et al. Modifying ligand-induced and constitutive signaling of the human 5–HT4 receptor. PLoS ONE 2, e1317 (2007).

    Article  Google Scholar 

  22. Hsiao, E.C. et al. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc. Natl. Acad. Sci. USA 105, 1209–1214 (2008).

    Article  CAS  Google Scholar 

  23. Pauwels, P.J. Unravelling multiple ligand-activation binding sites using RASSL receptors. Trends Pharmacol. Sci. 24, 504–507 (2003).

    Article  CAS  Google Scholar 

  24. Bender, D., Holschbach, M. & Stocklin, G. Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice. Nucl. Med. Biol. 21, 921–925 (1994).

    Article  CAS  Google Scholar 

  25. Pausch, M.H. G-protein-coupled receptors in Saccharomyces cerevisiae: high-throughput screening assays for drug discovery. Trends Biotechnol. 15, 487–494 (1997).

    Article  CAS  Google Scholar 

  26. Dohlman, H.G., Thorner, J., Caron, M.G. & Lefkowitz, R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60, 653–688 (1991).

    Article  CAS  Google Scholar 

  27. Li, B. et al. Rapid identification of functionally critical amino acids in a G protein-coupled receptor. Nat. Methods 4, 169–174 (2007).

    Article  CAS  Google Scholar 

  28. Minic, J., Sautel, M., Salesse, R. & Pajot-Augy, E. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors. Curr. Med. Chem. 12, 961–969 (2005).

    Article  CAS  Google Scholar 

  29. Shapiro, D.A., Kristiansen, K., Weiner, D.M., Kroeze, W.K. & Roth, B.L. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277, 11441–11449 (2002).

    Article  CAS  Google Scholar 

  30. Violin, J.D. & Lefkowitz, R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28, 416–422 (2007).

    Article  CAS  Google Scholar 

  31. Cherezov, V. et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258–1265 (2007).

    Article  CAS  Google Scholar 

  32. Roth, B.L. Drugs and valvular heart disease. N. Engl. J. Med. 356, 6–9 (2007).

    Article  CAS  Google Scholar 

  33. Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366, 381–416 (2002).

    Article  CAS  Google Scholar 

  34. Kenakin, T. Efficacy at G-protein-coupled receptors. Nat. Rev. Drug Discov. 1, 103–110 (2002).

    Article  CAS  Google Scholar 

  35. Srinivasan, S. et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 114, 1158–1164 (2004).

    Article  CAS  Google Scholar 

  36. Winzell, M.S. & Ahren, B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 116, 437–448 (2007).

    Article  CAS  Google Scholar 

  37. Scearce-Levie, K., Lieberman, M.D., Elliott, H.H. & Conklin, B.R. Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling. BMC Biol. 3, 3 (2005).

    Article  Google Scholar 

Download references

Acknowledgements

We thank our funding agencies and the members of our labs who have contributed to the RASSL projects: US National Institutes of Health (HL60664-07 to B.R.C.; DK072071 to R.A.N.; and U19MH82441 to B.L.R), a National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award (to B.L.R.), the American Heart Association pre-doctoral fellowship program (0415005Y to W.C.C.), the Veterans Affairs Merit Review and Career Scientist Program (R.A.N.) and the Gladstone–California Institute of Regenerative Medicine, fellowship program (grant T2-00003 to E.C.H.). The Gladstone Institutes received support from the US National Center for Research Resources Grant RR18928-01. We thank J. Ng, T. Nguyen, D. Srivastava, R.W. Mahley, H. Zahed, B. Phillips, M. Spindler, G. Howard and S. Ordway for providing valuable technical assistance and discussions.

Author information

Authors and Affiliations

  1. Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, 94158, California, USA

    Bruce R Conklin, Edward C Hsiao, W C Chang & Robert A Nissenson

  2. Departments of Medicine and Cellular and Molecular Pharmacology, University of California, San Francisco, 505 Parnassus Avenue, Room M994, San Francisco, 94122, California, USA

    Bruce R Conklin & Edward C Hsiao

  3. and Departments of Medicine and Physiology, Endocrine Research Unit, Veterans Affairs Medical Center, University of California, San Francisco, 4150 Clement Street, San Francisco, 94121, California, USA

    Edward C Hsiao & Robert A Nissenson

  4. Centre National de la Recherche Scientifique, UMR 5203, Institut de Génomique Fonctionnelle, 141 rue de la Cardonille and Institut National de la Santé et de la Recherche Médicale, U661, and Université Montpellier, Montpellier, 34094, France

    Sylvie Claeysen, Aline Dumuis & Joël Bockaert

  5. Department of Physiology, 600 16th St. University of California, San Francisco, San Francisco, 94143, California, USA

    Supriya Srinivasan

  6. Department of Neurosurgery, University of California, San Francisco, MCB 226, 1855 Folsom Street, San Francisco, 94103, California, USA

    John R Forsayeth

  7. Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 9000 Rockville Pike, Bethesda, 20892, Maryland, USA

    Jean-Marc Guettier & Jürgen Wess

  8. Graduate Program in Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, 1700 Fourth Street, Byers Hall, Suite BH-216, San Francisco, 94143, California, USA

    W C Chang

  9. Department of Pharmacology, University of North Carolina, Chapel Hill, 1106 Mary Ellen Jones Building, CB 7365, 98 Manning Drive, Chapel Hill, 27599, North Carolina, USA

    Ying Pei, Ken D McCarthy & Bryan L Roth

Authors
  1. Bruce R Conklin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward C Hsiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sylvie Claeysen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aline Dumuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Supriya Srinivasan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John R Forsayeth
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jean-Marc Guettier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W C Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ying Pei
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ken D McCarthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Robert A Nissenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Jürgen Wess
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Joël Bockaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Bryan L Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Bruce R Conklin or Bryan L Roth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conklin, B., Hsiao, E., Claeysen, S. et al. Engineering GPCR signaling pathways with RASSLs. Nat Methods 5, 673–678 (2008). https://doi.org/10.1038/nmeth.1232

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nmeth.1232

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing